Cargando…
Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR
BACKGROUND: Whether or not EGFR mutation status detected by ddPCR in plasma predicts the effect of icotinib on patients with advanced lung adenocarcinoma was determined. METHODS: Plasma and matched tissue specimens from patients with advanced lung adenocarcinoma were collected prior to icotinib trea...
Autores principales: | Chen, Hua-Fei, Lei, Lei, Wu, Li-Xin, Li, Xiao-Feng, Zhang, Qu-Xia, Pan, Wei-Wei, Min, Yong-Hua, Zhu, You-Cai, Du, Kai-Qi, Wang, Min, Wang, Wen-Xian, Xu, Chun-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798205/ https://www.ncbi.nlm.nih.gov/pubmed/35117043 http://dx.doi.org/10.21037/tcr.2019.10.48 |
Ejemplares similares
-
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR‐TKI resistance
por: Wang, Wenxian, et al.
Publicado: (2016) -
ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019) -
Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
por: Akahori, Daisuke, et al.
Publicado: (2021) -
Enhancing the compatibility of BioCaRGOS silica sol-gel technology with ctDNA extraction and droplet digital PCR (ddPCR) analysis
por: Potnis, Chinmay S., et al.
Publicado: (2022) -
Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
por: Guo, Qiao-mei, et al.
Publicado: (2019)